AI assistant
Sending…
ARTELO BIOSCIENCES, INC. — Director's Dealing 2021
Apr 20, 2021
35163_dirs_2021-04-20_041b0b82-9079-4d41-9eb0-5363e942eac9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARTELO BIOSCIENCES, INC. (ARTL)
CIK: 0001621221
Period of Report: 2021-04-16-05:00
Reporting Person: Gorgas Gregory D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-16-05:00 | Common Stock | P | 8500 | $1.154 | Acquired | 270676 | Direct |
Footnotes
F1: Represents the weighted average share price of an aggregate total of 8,500 shares purchased in the price range of $1.15 to $1.16 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
More from ARTELO BIOSCIENCES, INC.
Regulatory Filings
2026
May 27
Share Issue/Capital Change
2026
May 26
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 15
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
May 14
Capital/Financing Update
2026
Apr 16
Capital/Financing Update
2026
Apr 7
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27